Opthea Ltd Files October 2024 Corporate Presentation
Ticker: OPTEY · Form: 6-K · Filed: Oct 28, 2024 · CIK: 1815620
Sentiment: neutral
Topics: corporate-presentation, biotech, sec-filing
TL;DR
Opthea dropped its Oct 2024 corporate deck - check it for the latest on their biotech plays.
AI Summary
Opthea Limited filed a Form 6-K on October 28, 2024, to report its corporate presentation from October 2024. The filing includes a press release detailing the presentation, which likely covers the company's business, financial status, and strategic outlook in the biological products sector.
Why It Matters
This filing provides investors with an updated overview of Opthea's business strategy and progress, crucial for understanding the company's trajectory in the competitive biopharmaceutical landscape.
Risk Assessment
Risk Level: medium — As a biopharmaceutical company, Opthea faces inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Players & Entities
- Opthea Limited (company) — Registrant
- October 2024 (date) — Presentation date
- 20241028 (date) — Filing date
- 001-39621 (other) — SEC File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a press release containing Opthea Limited's Corporate Presentation from October 2024.
When was this filing submitted to the SEC?
This filing was submitted to the SEC on October 28, 2024.
What type of company is Opthea Limited?
Opthea Limited is classified under the Standard Industrial Classification code 2836, which pertains to Biological Products (no diagnostic substances).
Where is Opthea Limited's principal executive office located?
Opthea Limited's principal executive office is located at Level 4, 650 Chapel Street, South Yarra, Victoria, 3141, Australia.
Does Opthea Limited file annual reports under Form 20-F or Form 40-F?
Opthea Limited files annual reports under Form 20-F, as indicated by the checkmark next to 'Form 20-F'.
Filing Stats: 147 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-10-28 06:03:57
Filing Documents
- opt_corporate_presentati.htm (6-K) — 23KB
- opt-ex99_1.htm (EX-99.1) — 45KB
- opt-ex99_1s1.jpg (GRAPHIC) — 268KB
- opt-ex99_1s2.jpg (GRAPHIC) — 1000KB
- opt-ex99_1s3.jpg (GRAPHIC) — 470KB
- opt-ex99_1s4.jpg (GRAPHIC) — 360KB
- opt-ex99_1s5.jpg (GRAPHIC) — 385KB
- opt-ex99_1s6.jpg (GRAPHIC) — 349KB
- opt-ex99_1s7.jpg (GRAPHIC) — 291KB
- opt-ex99_1s8.jpg (GRAPHIC) — 341KB
- opt-ex99_1s9.jpg (GRAPHIC) — 330KB
- opt-ex99_1s10.jpg (GRAPHIC) — 350KB
- opt-ex99_1s11.jpg (GRAPHIC) — 345KB
- opt-ex99_1s12.jpg (GRAPHIC) — 387KB
- opt-ex99_1s13.jpg (GRAPHIC) — 356KB
- opt-ex99_1s14.jpg (GRAPHIC) — 375KB
- opt-ex99_1s15.jpg (GRAPHIC) — 293KB
- opt-ex99_1s16.jpg (GRAPHIC) — 406KB
- opt-ex99_1s17.jpg (GRAPHIC) — 269KB
- opt-ex99_1s18.jpg (GRAPHIC) — 330KB
- opt-ex99_1s19.jpg (GRAPHIC) — 278KB
- opt-ex99_1s20.jpg (GRAPHIC) — 411KB
- opt-ex99_1s21.jpg (GRAPHIC) — 281KB
- opt-ex99_1s22.jpg (GRAPHIC) — 291KB
- opt-ex99_1s23.jpg (GRAPHIC) — 298KB
- opt-ex99_1s24.jpg (GRAPHIC) — 273KB
- opt-ex99_1s25.jpg (GRAPHIC) — 350KB
- opt-ex99_1s26.jpg (GRAPHIC) — 534KB
- opt-ex99_1s27.jpg (GRAPHIC) — 395KB
- opt-ex99_1s28.jpg (GRAPHIC) — 327KB
- opt-ex99_1s29.jpg (GRAPHIC) — 282KB
- opt-ex99_1s30.jpg (GRAPHIC) — 277KB
- opt-ex99_1s31.jpg (GRAPHIC) — 404KB
- opt-ex99_1s32.jpg (GRAPHIC) — 370KB
- opt-ex99_1s33.jpg (GRAPHIC) — 444KB
- opt-ex99_1s34.jpg (GRAPHIC) — 384KB
- 0000950170-24-117543.txt ( ) — 17284KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 10/28/2024